The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Metastasis: a therapeutic target for cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer
Wang, J., Wang, J., Dai, J., Jung, Y., Wei, C.-L., Wang, Y., Havens, A. M., Hogg, P. J., Keller, E. T., Pienta, K. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2971 · Cited by 152
RetractedSlamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
Hicklin, D. J., & Ellis, L. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.081 · Cited by 3,007
Metastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
Self-citationHolmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
Vascular Endothelial Growth Factor
Ferrara, N. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179663 · Cited by 1,283
Lamon, D. E. J. S., Eyland, B. R. L., Hak, S. T. S., Uchs, H. A. F., Aton, V. I. P., Ajamonde, A. L. B., LeMing, T., Iermann, W. O. E., Olter, J. A. W., Egram, M. A. P., et al. (2009) · Cited by 1,199
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Chieh Lin, H., Yancopoulos, G. D., & Thurston, G. (2006) · Nature · doi:10.1038/nature05355 · Cited by 1,032
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
Ridgway, J., Zhang, G., Wu, Y., Stawicki, S., Liang, W.-C., Chanthery, Y., Kowalski, J., Watts, R. J., Callahan, C., Kasman, I., et al. (2006) · Nature · doi:10.1038/nature05313 · Cited by 986
Regulation of cancer cell migration and bone metastasis by RANKL.
Jones, D. H., Nakashima, T., Sanchez, O. H., Kozieradzki, I., Komarova, S. V., Sarosi, I., Morony, S., Rubin, E., Sarao, R., Hojilla, C. V., et al. (2006) · Nature · doi:10.1038/nature04524 · Cited by 796
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis
Gupta, G. P., Nguyen, D. X., Chiang, A. C., Bos, P. D., Kim, J. Y., Nadal, C., Gomis, R. R., Manova-Todorova, K., & Massagué, J. (2007) · Nature · doi:10.1038/nature05760 · Cited by 727
The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
Deeken, J. F., & Löscher, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2854 · Cited by 721
Al-Mehdi, A. B., Tozawa, K., Fisher, A. B., Shientag, L., Lee, A., & Muschel, R. J. (2000) · Nature Medicine · doi:10.1038/71429 · Cited by 706
Feldmann, G., Dhara, S., Fendrich, V., Bedja, D., Beaty, R., Mullendore, M., Karikari, C., Alvarez, H., Iacobuzio-Donahue, C., Jimeno, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3281 · Cited by 694
Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases
Shah, R. B., Mehra, R., Chinnaiyan, A. M., Shen, R., Ghosh, D., Zhou, M., MacVicar, G. R., Varambally, S., Harwood, J., Bismar, T. A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2442 · Cited by 617
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
Kang, Y., He, W., Tulley, S., Gupta, G. P., Serganova, I., Chen, C.-R., Manova-Todorova, K., Blasberg, R., Gerald, W. L., & Massagué, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506517102 · Cited by 532
Herbst, R. S., Johnson, D. H., Mininberg, E., Carbone, D. P., Henderson, T., Kim, E. S., Blumenschein, G., Lee, J. J., Liu, D. D., Truong, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.477 · Cited by 530
Wedam, S. B., Low, J. A., Yang, S. X., Chow, C. K., Choyke, P., Danforth, D., Hewitt, S. M., Berman, A., Steinberg, S. M., Liewehr, D. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4645 · Cited by 518
Nierodzik, M. L., & Karpatkin, S. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.002 · Cited by 502
Body, J.-J., Facon, T., Coleman, R. E., Lipton, A., Geurs, F., Fan, M., Holloway, D., Peterson, M. C., & Bekker, P. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1933 · Cited by 490
Postoperative Nomogram Predicting Risk of Recurrence After Radical Cystectomy for Bladder Cancer
(2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3884 · Cited by 460
Targeting the c-Met Signaling Pathway in Cancer
Peruzzi, B., & Bottaro, D. P. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0818 · Cited by 448
Jubb, A. M., Hurwitz, H. I., Bai, W., Holmgren, E. B., Tobin, P., Guerrero, A. S., Kabbinavar, F., Holden, S. N., Novotny, W. F., Frantz, G. D., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5388 · Cited by 387
Body, J.-J., Greipp, P., Coleman, R. E., Facon, T., Geurs, F., Fermand, J.-P., Harousseau, J.-L., Lipton, A., Mariette, X., Williams, C. D., et al. (2003) · Cancer · doi:10.1002/cncr.11138 · Cited by 383
Randomized, Placebo-Controlled Trial of Clodronate in Patients With Primary Operable Breast Cancer
Powles, T., Paterson, S., Kanis, J. A., McCloskey, E., Ashley, S., Tidy, A., Rosenqvist, K., Smith, I., Ottestad, L., Legault, S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.080 · Cited by 377
Biswas, S., Guix, M., Rinehart, C., Dugger, T. C., Chytil, A., Moses, H. L., Freeman, M. L., & Arteaga, C. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30740 · Cited by 346
Saarto, T., Blomqvist, C., Virkkunen, P., & Elomaa, I. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.10 · Cited by 341
Naumov, G. N., MacDonald, I. C., Weinmeister, P. M., Kerkvliet, N. I., Nadkarni, K. V., Wilson, S. M., Morris, V. L., Groom, A. C., & Chambers, A. F. (2002) · PubMed · Cited by 341
Park, B. K., Zhang, H., Zeng, Q., Dai, J., Keller, E. T., Giordano, T., Gu, K., Shah, V., Pei, L., Zarbo, R. J., et al. (2007) · Nature Medicine · doi:10.1038/nm1519 · Cited by 325
Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone
Roudier, M. P., True, L. D., Higano, C. S., Vesselle, H., Ellis, W., Lange, P., & Vessella, R. L. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00190-4 · Cited by 311
Treatment of Metastatic Renal Cell Carcinoma With a Combination of Bevacizumab and Erlotinib
Hainsworth, J. D., Sosman, J. A., Spigel, D. R., Edwards, D. L., Baughman, C., & Greco, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.8234 · Cited by 303
Palm, D., Lang, K., Niggemann, B., Drell, T. L., Masur, K., Zaenker, K. S., & Entschladen, F. (2006) · International Journal of Cancer · doi:10.1002/ijc.21723 · Cited by 298
Fatal Melanoma Transferred in a Donated Kidney 16 Years after Melanoma Surgery
MacKie, R. M., Reid, R., & Junor, B. (2003) · New England Journal of Medicine · doi:10.1056/nejm200302063480620 · Cited by 290
Important advances in oncology 1994
Holmes, M. E. (1994) · Surgical Oncology · doi:10.1016/0960-7404(94)90075-2 · Cited by 281
Horsman, M. R., & Siemann, D. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2848 · Cited by 246
Cairns, R. A., & Hill, R. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3196 · Cited by 216
Stessels, F., Van den Eynden, G., Van der Auwera, I., Salgado, R., Van den Heuvel, E., Harris, A. L., Jackson, D. G., Colpaert, C. G., Van Marck, E. A., Dirix, L. Y., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601727 · Cited by 214
Miller, K. D., Trigo, J. M., Wheeler, C., Barge, A., Rowbottom, J., Sledge, G., & Baselga, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1923 · Cited by 198
Bandyopadhyay, A., Agyin, J. K., Wang, L., Tang, Y., Lei, X., Story, B. M., Cornell, J. E., Pollock, B. H., Mundy, G. R., & Sun, L.-Z. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3565 · Cited by 185
Diep, C. B., Kleivi, K., Ribeiro, F. R., Teixeira, M. R., Lindgjærde, O. C., & Lothe, R. A. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20261 · Cited by 178
Hao, X., Sun, B., Hu, L., Lähdesmäki, H., Dunmire, V., Feng, Y., Zhang, S., Wang, H., Wu, C., Wang, H., et al. (2004) · Cancer · doi:10.1002/cncr.20095 · Cited by 168
Nash, K. T., Phadke, P. A., Navenot, J.-M., Hurst, D. R., Accavitti-Loper, M. A., Sztul, E., Vaidya, K. S., Frost, A. R., Kappes, J. C., Peiper, S. C., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk053 · Cited by 167
The tumor microenvironment in the post-PAGET era
Witz, I. P., & Levy‐Nissenbaum, O. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.12.005 · Cited by 161
Biology of colorectal liver metastases: A review
Bird, N. C., MANGNALL, D., & Majeed, A. W. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20558 · Cited by 159
The Biology of Metastasis to a Sanctuary Site
Palmieri, D., Chambers, A. F., Felding‐Habermann, B., Huang, S., & Steeg, P. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2659 · Cited by 156
Self-citationKüsters, B., Leenders, W. P. J., Wesseling, P., Smits, D., Verrijp, K. C. N., Ruiter, D. J., Peters, J. P. W., van der Kogel, A. J., & de Waal, R. M. W. (2002) · PubMed · Cited by 152
Jallal, H., Valentino, M.-L., Chen, G., Boschelli, F., Ali, S., & Rabbani, S. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2027 · Cited by 149
Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis
Dorrell, M. I., Aguilar, E., Scheppke, L., Barnett, F. H., & Friedlander, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607542104 · Cited by 147
Neville-Webbe, H. L., Cross, N. A., Eaton, C. L., Nyambo, R., Evans, C. A., Coleman, R. E., & Holen, I. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000036900.48763.b3 · Cited by 142
Rucci, N., Recchia, I., Angelucci, A., Alamanou, M., Fattore, A. D., Fortunati, D., Šuša, M., Fabbro, D., Bologna, M., & Teti, A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102004 · Cited by 141
Palmieri, D., Halverson, D. O., Ouatas, T., Horak, C. E., Salerno, M., Johnson, J. A., Figg, W. D., Hollingshead, M. G., Hursting, S. D., Berrigan, D. A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji111 · Cited by 124
Self-citationTumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability
Criscuoli, M. L., Nguyen, M. T. N., & Eliceiri, B. P. (2004) · Blood · doi:10.1182/blood-2004-06-2246 · Cited by 121
Influence of the Microenvironment on Melanoma Cell Fate Determination and Phenotype
Postovit, L.-M. M., Seftor, E. A., Seftor, R. E. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0731 · Cited by 119
Involvement of Insulin Receptor Substrate 2 in Mammary Tumor Metastasis
Nagle, J. A., Ma, Z., Byrne, M. A., White, M. F., & Shaw, L. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9726-9735.2004 · Cited by 117
Endothelin Axis Is a Target of the Lung Metastasis Suppressor Gene RhoGDI2
Titus, B. J., Frierson, H. F., Conaway, M. R., Ching, K., Guise, T. A., Chirgwin, J. M., Hampton, G. M., & Theodorescu, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1403 · Cited by 106
Self-citationSuzuki, M., & Tarin, D. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.03.005 · Cited by 94
The tumor microenvironment as a determinant of drug response and resistance
Dalton, W. S. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0097 · Cited by 92
Nm23-H1 Suppresses Metastasis by Inhibiting Expression of the Lysophosphatidic Acid Receptor EDG2
Horak, C. E., Mendoza, A., Vega-Valle, E., Albaugh, M. E., Graff‐Cherry, C., McDermott, W. G., Hua, E., Merino, M. J., Steinberg, S. M., Khanna, C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3175 · Cited by 92
Self-citationAlbanese, I., Scibetta, A. G., Migliavacca, M., Russo, A., Bazan, V., Tomasino, R. M., Colomba, P., Tagliavia, M., & La Farina, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.111 · Cited by 91
Yanagawa, R., Furukawa, Y., Tsunoda, T., Kitahara, O., Kameyama, M., Murata, K., Ishikawa, O., & Nakamura, Y. (2001) · Neoplasia · doi:10.1038/sj.neo.7900185 · Cited by 91
Griend, D. J. V., Kocherginsky, M., Hickson, J. A., Stadler, W. M., Lin, A., & Rinker-Schaeffer, C. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2382 · Cited by 91
Nam, J., Suchar, A. M., Kang, M., Stuelten, C. H., Tang, B., Michalowska, A. M., Fisher, L. W., Fedarko, N. S., Jain, A., Pinkas, J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0068 · Cited by 86
Orsini, M. J., Klein, M. A., Beavers, M. P., Connolly, P. J., Middleton, S. A., & Mayo, K. H. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0609824 · Cited by 83
Martin, S. S., Ridgeway, A. G., Pinkas, J., Lu, Y., Reginato, M. J., Koh, E. Y., Ventosa-Michelman, M., Daley, G. Q., Brugge, J. S., & Leder, P. (2004) · Oncogene · doi:10.1038/sj.onc.1207595 · Cited by 83
Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247
Shannon, K. E., Keene, J. L., Settle, S. L., Duffin, T. D., Nickols, M. A., Westlin, M. M., Schroeter, S., Ruminski, P., & Griggs, D. W. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000024764.93092.5f · Cited by 76
Kishida, Y., Yoshikawa, H., & Myoui, A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1559 · Cited by 75
Biswas, S., Criswell, T. L., Wang, S. E., & Arteaga, C. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0952 · Cited by 69
Maintenance of Head and Neck Tumor Gene Expression Profiles upon Lymph Node Metastasis
Roepman, P., Jager, A., Koerkamp, M. J. A. G., Kummer, J. A., Slootweg, P. J., & Holstege, F. C. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3161 · Cited by 69
Wang, L., Zhu, J.-S., Song, M.-Q., Chen, G.-Q., & Chen, J.-L. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i43.6949 · Cited by 68
Targeting the c-Met Signaling Pathway in Cancer
Peruzzi, B., & Bottaro, D. P. (2008) · AACR Education book · doi:10.1158/aacr.edb-ccr-06-0818 · Cited by 58
Zhang, Q., Yang, X. J., KUNDU, S. D., Pins, M., Javonovic, B., Meyer, R., Kim, S., Greenberg, N. M., Kuzel, T. M., Meagher, R., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0109 · Cited by 56
Tosi, P., Zamagni, E., Cellini, C., Parente, R., Cangini, D., Tacchetti, P., Perrone, G., Ceccolini, M., Boni, P., Tura, S., et al. (2006) · European Journal Of Haematology · doi:10.1111/j.0902-4441.2005.t01-1-ejh2520.x · Cited by 55
Efstathiou, E., Troncoso, P., Wen, S., Do, K.-A., Pettaway, C. A., Pisters, L. L., McDonnell, T. J., & Logothetis, C. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1938 · Cited by 53
Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinone RPI-1
Cassinelli, G., Lanzi, C., Petrangolini, G., Tortoreto, M., Pratesi, G., Cuccuru, G., Laccabue, D., Supino, R., Belluco, S., Favini, E., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0245 · Cited by 45
Giubellino, A., Gao, Y., Lee, S., Lee, M.-J., Vasselli, J. R., Medepalli, S., Trepel, J. B., Burke, T. R., & Bottaro, D. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0022 · Cited by 41
Ono, K., Kamiya, S., Akatsu, T., Nakamura, C., Li, M., Amizuka, N., Matsumoto, K., Nakamura, T., Kugai, N., & Wada, S. (2006) · Bone · doi:10.1016/j.bone.2005.12.006 · Cited by 34
Khalili, P., Arakelian, A., Chen, G., Singh, G., & Rabbani, S. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208790 · Cited by 29
den Eynden, G. G. V., Laere, S. V., der Auwera, I. V., Gilles, L., Burn, J. L., Colpaert, C., van Dam, P. A., Marck, E. A. V., Dirix, L. Y., & Vermeulen, P. B. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9049-3 · Cited by 25
Lang, J., Chen, H., Zhou, J. R., Zhang, Y., Zhang, X., Li, M.-H., Lin, L., Zhang, J.-S., Waalkes, M. P., & Ding, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2026 · Cited by 25
The Role of Bisphosphonates in Early Breast Cancer
Paterson, A. H. G. (2006) · The Oncologist · doi:10.1634/theoncologist.11-90001-13 · Cited by 21
Mario, L. (2005) · Frontiers in bioscience · doi:10.2741/1761 · Cited by 19
Cited by
Steeg, P. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.25 · Cited by 1,363
Self-citationTherapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Ma, L., Reinhardt, F., Pan, E., Soutschek, J., Bhat, B., Marcusson, E. G., Teruya-Feldstein, J., Bell, G. W., & Weinberg, R. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1618 · Cited by 772
Defining the Hallmarks of Metastasis
Welch, D. R., & Hurst, D. R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0458 · Cited by 700
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
Ebos, J. M. L., & Kerbel, R. S. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.21 · Cited by 685
“The limitations of these studies are of particular relevance because metastasis is generally the cause of patient mortality”
BackgroundThe tumor microenvironment and its contribution to tumor evolution toward metastasis
Lorusso, G., & Rüegg, C. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0530-8 · Cited by 531
Metadata
- Authors
- Steeg, P. S., & Theodorescu, D.
- Venue
- Nature Clinical Practice Oncology
- Published
- 2008-02-05
- Volume
- 5
- Issue
- 4
- Pages
- 206-219
- ISSN
- 1743-4254 (ISSN-L)
- 1743-4262
- OpenAlex
- W2156503775
- Cited by
- 332
- References
- 92
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.